Trina Racine

Prince Albert, SK, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.

Journal: Human vaccines & immunotherapeutics
Published: June 10, 2026

Efficient design and production of glycosylated PEDV spike S1 protein.

Efficient design and production of glycosylated PEDV spike S1 protein.

Journal: Scientific reports
Published: February 17, 2026

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.

Journal: Vaccine
Published: July 30, 2025

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.

Journal: Vaccine
Published: April 09, 2024

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.

Journal: Vaccines
Published: January 31, 2024

Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen.

Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen.

Journal: Emerging microbes & infections
Published: August 31, 2023

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.

Journal: Vaccines
Published: April 08, 2023

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.

Journal: The New England journal of medicine
Published: September 15, 2021

Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in Macaques.

Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in Macaques.

Journal: The Journal of infectious diseases
Published: June 10, 2021

Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment.

Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment.

Journal: Microorganisms
Published: January 30, 2021

A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.

A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.

Journal: Vaccine
Published: October 21, 2020

Modeling host-feeding preference and molecular systematics of mosquitoes in different ecological niches in Canada.

Modeling host-feeding preference and molecular systematics of mosquitoes in different ecological niches in Canada.

Journal: Acta tropica
Published: September 10, 2020
Showing 1-12 of 41

Last Updated: 09/26/2026